Source: Annual Congress 2006 - Pulmonary arterial hypertension: from bench back to bedside
Disease area: Interstitial lung diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
V. S. Nikam, K. Ahlbrecht, N. Weissmann, P. Koenig, J. Lohmeyer, W. Seeger, R. Voswinckel (Giessen, Germany). Circulating fibrocytes: a role in pulmonary circulation?. Eur Respir J 2006; 28: Suppl. 50, 3153

Member's Comments

No comment yet.

Related content which might interest you: Circulating fibrocytes and pulmonary arterial hypertension Source: Eur Respir J 2011; 39: 210-212 Year: 2012 Circulating fibrocytes and pulmonary arterial hypertension Source: Eur Respir J 2012; 39: 210-212 Year: 2012 Circulating fibrocytes in pulmonary arterial hypertension Source: Annual Congress 2011 - Clinical characteristics of patients with pulmonary hypertension Year: 2011 Treprostinil inhibits the recruitment of bone marrow-derived circulating fibrocytes in chronic hypoxic pulmonary hypertension Source: Eur Respir J 2010; 36: 1302-1314 Year: 2010 Imbalance between circulating endothelial cells and endothelial progenitors in idiopathic pulmonary fibrosis Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis? Year: 2011 Circulating endothelial progenitor cells in COPD: effect of pulmonary hypertension Source: Annual Congress 2007 - Cellular and molecular aspects of pulmonary hypertension Year: 2007 Plasticity of vascular progenitor cells: implications in pulmonary vascular remodeling in COPD Source: Eur Respir J 2006; 28: Suppl. 50, 803s Year: 2006 Circulating fibrocytes in interstitial lung disease Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies Year: 2008 Plasticity of vascular progenitor cells: Implications in pulmonary vascular remodelling in COPD Source: Eur Respir Rev 2006; 15: 209-210 Year: 2006 Role of IL-11 in vascular function of pulmonary fibrosis patients Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension Year: 2019 Increased fibrinolytic mediators in IPF as potential contributors to pulmonary fibrosis and vascular remodeling Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 Circulating endothelial progenitor cells in patients with idiopathic pulmonary fibrosis (preliminary results) Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology? Year: 2008 Late Breaking Abstract - NGF induces pulmonary arterial hyperreactivity through increased connexin-43 expression: potential role in pulmonary hypertension Source: International Congress 2018 – Molecular mechanisms and treatment of pulmonary hypertension Year: 2018 Roles of circulating and resident myeloid cell subpopulations in bronchopulmonary remodeling and pulmonary hypertension Source: Annual Congress 2013 –Pulmonary circulation: basic science Year: 2013 Nuclear IL-33 arguments ST2 receptor expression in pulmonary arterial endothelial cells: Implication in the pathogenesis and progression of pulmonary arterial hypertension Source: International Congress 2014 – Pulmonary hypertension: pathobiology Year: 2014 Autoimmunity and pulmonary arterial hypertension: The role of leptin Source: Annual Congress 2011 - Experimental pulmonary hypertension Year: 2011